US 9486456
Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof
granted A61KA61K31/4985A61K31/519
Quick answer
US patent 9486456 (Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof) held by The Board of Regents of the University of Texas System expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/4985, A61K31/519, A61K45/06, A61P